SP
Steven M Paul (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Rapport Therapeutics, Inc. (RAPP). The largest single filing was $974K of RAPP (35,714 sh × $27.28, as filed), executed Oct 22. The median gap between execution and disclosure was 0 days. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
purchases not yet priced
Delay-adjustediThe same average, entered at disclosure dates
–
purchases not yet priced
Filings, ttm
1
1 buys · 0 sells
Median delay
0d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$974K
shares × price, as filed
Last traded
Oct 22
Filed Oct 22
Median ADV $17.2M across their filed names
100% of their measured filings could not be priced (delisted or unquoted names). The returns above cover only what still trades.
Open performance→Volume by month
Buys $2.0M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
RAPPRecent filings
RAPPPURCHASE
Rapport Therapeutics, Inc.
View filing →
$974K35,714 sh × $27.28
Exec Oct 22
Filed Oct 22 · 4:56 PM ET RAPPPURCHASE Rapport Therapeutics, Inc. View filing → $1.0M
41,666 sh across 2 lots
Exec Sep 12 2025
Filed Sep 15 2025 · 4:05 PM ET